PL374993A1 - Nowe krystaliczne postaci gatifloksacyny - Google Patents
Nowe krystaliczne postaci gatifloksacynyInfo
- Publication number
- PL374993A1 PL374993A1 PL03374993A PL37499303A PL374993A1 PL 374993 A1 PL374993 A1 PL 374993A1 PL 03374993 A PL03374993 A PL 03374993A PL 37499303 A PL37499303 A PL 37499303A PL 374993 A1 PL374993 A1 PL 374993A1
- Authority
- PL
- Poland
- Prior art keywords
- gatifloxacin
- crystalline forms
- novel crystalline
- novel
- forms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40167202P | 2002-08-06 | 2002-08-06 | |
| US40274902P | 2002-08-12 | 2002-08-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL374993A1 true PL374993A1 (pl) | 2005-11-14 |
Family
ID=31498702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL03374993A PL374993A1 (pl) | 2002-08-06 | 2003-08-06 | Nowe krystaliczne postaci gatifloksacyny |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7396839B2 (pl) |
| EP (1) | EP1545530A1 (pl) |
| JP (1) | JP2006508909A (pl) |
| AU (1) | AU2003258109A1 (pl) |
| CA (1) | CA2494518A1 (pl) |
| IL (1) | IL166592A0 (pl) |
| PL (1) | PL374993A1 (pl) |
| WO (1) | WO2004012739A1 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005082920A1 (en) * | 2004-02-27 | 2005-09-09 | H. Lundbeck A/S | Crystalline forms of a pharmaceutical compound |
| WO2005118546A1 (en) | 2004-06-04 | 2005-12-15 | Matrix Laboratories Ltd | Novel crystalline forms of gatifloxacin |
| FR2875807B1 (fr) * | 2004-09-30 | 2006-11-17 | Servier Lab | Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent |
| EP1971593A2 (en) * | 2005-12-12 | 2008-09-24 | Medichem, S.A. | Improved synthesis and preparations of duloxetine salts |
| TW201016675A (en) * | 2008-09-16 | 2010-05-01 | Mitsubishi Tanabe Pharma Corp | Crystalline benzoimidazole compound and salt thereof |
| MY180626A (en) | 2013-11-15 | 2020-12-03 | Akebia Therapeutics Inc | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2128601C (en) * | 1992-01-31 | 2003-07-15 | Hiroyuki Nagano | Quinolone carboxylic acid derivatives in crystalline hydrate form |
| JP3449658B2 (ja) * | 1994-12-21 | 2003-09-22 | 杏林製薬株式会社 | 安定性に優れた８−アルコキシキノロンカルボン酸水和物並びにその製造方法 |
| US6413969B1 (en) | 2000-09-13 | 2002-07-02 | Bristol-Myers Squibb Company | Gatifloxacin pentahydrate |
| US20060142300A1 (en) | 2002-04-08 | 2006-06-29 | Reddy Manne S | Anhydrous crystalline forms of I and II of 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1- piperazinyl) 4-oxo-1, 4-dihydroquinoline-3-carboxylic acid (gatifloxacin) |
-
2003
- 2003-08-06 PL PL03374993A patent/PL374993A1/pl unknown
- 2003-08-06 JP JP2004526061A patent/JP2006508909A/ja active Pending
- 2003-08-06 US US10/635,337 patent/US7396839B2/en not_active Expired - Fee Related
- 2003-08-06 EP EP03767250A patent/EP1545530A1/en not_active Withdrawn
- 2003-08-06 CA CA002494518A patent/CA2494518A1/en not_active Abandoned
- 2003-08-06 WO PCT/US2003/024615 patent/WO2004012739A1/en not_active Ceased
- 2003-08-06 AU AU2003258109A patent/AU2003258109A1/en not_active Abandoned
-
2005
- 2005-01-31 IL IL16659205A patent/IL166592A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2494518A1 (en) | 2004-02-12 |
| EP1545530A1 (en) | 2005-06-29 |
| WO2004012739A1 (en) | 2004-02-12 |
| JP2006508909A (ja) | 2006-03-16 |
| US7396839B2 (en) | 2008-07-08 |
| AU2003258109A1 (en) | 2004-02-23 |
| US20040192700A1 (en) | 2004-09-30 |
| IL166592A0 (en) | 2006-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003230192A1 (en) | Novel crystalline forms of aripiprazole | |
| IL165584A0 (en) | Novel formate salt of o-desmethyl-venlafaxine | |
| AP1955A (en) | Novel crystalline modification of the anhydrate ofboscalid | |
| IL165115A0 (en) | Novel crystalline forms of gatifloxacin | |
| AU2003297594A8 (en) | Crystalline form | |
| AU2003245029A1 (en) | Novel crystalline forms of donepezil hydrochloride | |
| AU2003245027A1 (en) | Novel crystalline forms of ziprasidone hydrochloride | |
| AU2003238671A1 (en) | Novel crystalline forms of s-omeprazole magnesium | |
| IL172006A0 (en) | Novel crystalline forms of valacyclovir hydrochloride | |
| AU2003232719A1 (en) | Novel crystalline forms of valacyclovir hydrochloride | |
| AU2003295638A8 (en) | Novel inhibitors of beta-lactamase | |
| IL166592A0 (en) | Novel crystalline forms of gatifloxacin | |
| AU2003217438A1 (en) | Novel crystalline forms of levetiracetam | |
| IL165690A0 (en) | Novel crystalline forms of gatifloxacin | |
| AU2003217437A1 (en) | Novel crystalline forms of lamotrigine | |
| AU2003298725A8 (en) | Preparation of metallotexaphyrins | |
| PL375437A1 (pl) | Synteza gatifloksacyny | |
| AU2003300874A1 (en) | Crystalline forms of gatifloxacin and processes for preparation | |
| EP1486485A4 (en) | NEW 5-HYDROXYCARBAMIMIDOYL-2-HYDROXYBENZENESULFONAMIDE DERIVATIVE CRYSTALS | |
| AU2003230194A1 (en) | Novel crystalline forms of gatifloxacin | |
| GB0329236D0 (en) | Crystalline forms of (+)- and (-)- erthro-mefloquine hydrochloride | |
| IL174063A0 (en) | Crystalline form of gatifloxacin | |
| AU2003238668A1 (en) | Novel crystalline forms of valdecoxib | |
| GB0227730D0 (en) | Novel production of biocompounds | |
| AU2003209670A1 (en) | Novel crystalline forms of trandolapril |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |